Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) – Wedbush decreased their Q1 2025 earnings estimates for Mersana Therapeutics in a report issued on Monday, March 3rd. Wedbush analyst D.

CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...

GOP lawmaker says Republicans in his district aren't happy with Trump's handling of Russia and Ukraine ...

Sting from a scorpion Onset of local pain and tingling after a scorpion is seen in the area The main symptoms are pain, tingling and numbness at the sting site About 85% cause only local symptoms at ...

Set in the 1930's this intricate caper deals with an ambitious small-time crook and a veteran con man who seek revenge on a vicious crime lord who murdered one of their gang.

After hours: 7 March at 19:56:25 GMT-5 Loading Chart for MRSN ...